Kira Pharmaceuticals

R&D company focused on manufacturing of drugs for multiple therapeutic areas

placeHong Kong, Hong Kong, China calendar_todayFounded 2017 groups39 employees language kirapharma.com

Innovation

4 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 48 times.

YearFilings
20222
20234
20244
20252

Investor mix

10 investors on record; lead investors include RA Capital Management, Vivo Capital, Quan Capital, Qiming Venture Partners.

Investor typeCountShare
Venture capital550%
Private equity330%
Other / undisclosed220%
Coming soon